Literature DB >> 17685487

Abnormal venous and arterial patterning in Chordin mutants.

Emmanuèle C Délot1, Natalya Shneyder, Hanwei Zhang, Daniel Bachiller.   

Abstract

Classic dye injection methods yielded amazingly detailed images of normal and pathological development of the cardiovascular system. However, because these methods rely on the beating heart of diffuse the dyes, the vessels visualized have been limited to the arterial tree, and our knowledge of vein development is lagging. In order to solve this problem, we injected pigmented methylsalicylate resins in mouse embryos after they were fixed and made transparent. This new technique allowed us to image the venous system and prompted the discovery of multiple venous anomalies in Chord-/- mutant mice. Genetic inactivation of Chordin, an inhibitor of the Bone Morphogenetic Protein signaling pathway, results in neural crest defects affecting heart and neck organs, as seen in DiGeorge syndrome patients. Injection into the descending aorta of Chrd-/- mutants demonstrated how a very severe early phenotype of the aortic arches develops into persistent truncus arteriosus. In addition, injection into the atrium revealed several patterning defects of the anterior cardinal veins and their tributaries, including absence of segments, looping and midline defects. The signals that govern the development of the individual cephalic veins are unknown, but our results show that the Bone Morphogenetic Protein pathway is necessary for the process. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17685487     DOI: 10.1002/dvdy.21287

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  4 in total

1.  Cre reporter mouse expressing a nuclear localized fusion of GFP and beta-galactosidase reveals new derivatives of Pax3-expressing precursors.

Authors:  Jason Z Stoller; Karl R Degenhardt; Li Huang; Diane D Zhou; Min Min Lu; Jonathan A Epstein
Journal:  Genesis       Date:  2008-04       Impact factor: 2.487

2.  Crossveinless-2 is required for the relocalization of Chordin protein within the vertebral field in mouse embryos.

Authors:  Lise Zakin; Ellen Y Chang; Jean-Louis Plouhinec; E M De Robertis
Journal:  Dev Biol       Date:  2010-08-31       Impact factor: 3.582

3.  Notochord-derived BMP antagonists inhibit endothelial cell generation and network formation.

Authors:  Michael Bressan; Patricia Davis; John Timmer; Doris Herzlinger; Takashi Mikawa
Journal:  Dev Biol       Date:  2008-11-12       Impact factor: 3.582

4.  Chordin is a modifier of tbx1 for the craniofacial malformations of 22q11 deletion syndrome phenotypes in mouse.

Authors:  Murim Choi; John Klingensmith
Journal:  PLoS Genet       Date:  2009-02-27       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.